Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).
AUTOR(ES)
Traub, W H
RESUMO
A total of 144 clinical isolates of Acinetobacter species, i.e., A. baumannii (n = 60), genospecies 3 (n = 48), A. haemolyticus (n = 12), and genospecies 6 (n = 24), were examined comparatively with the agar dilution method of the National Committee for Clinical Laboratory Standards for susceptibility to 25 antimicrobial drugs. Only minor species differences were noted.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172714Documentos Relacionados
- Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore.
- Antimicrobial Susceptibility and Mechanisms of Resistance to Quinolones and β-Lactams in Acinetobacter Genospecies 3
- In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.
- Antimicrobial susceptibility of Acinetobacter species.
- Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001
